HomeCompareRENEW vs JNJ

RENEW vs JNJ: Dividend Comparison 2026

RENEW yields 1468.43% · JNJ yields 3.36%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 RENEW wins by $578330482.22M in total portfolio value
10 years
RENEW
RENEW
● Live price
1468.43%
Share price
$0.14
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$578330482.24M
Annual income
$510,008,244,050,066.40
Full RENEW calculator →
JNJ
Johnson & Johnson
● Live price
3.36%
Share price
$147.50
Annual div
$4.96
5Y div CAGR
5.8%
Payout ratio
55%
After 10 yrs · $10,000 · DRIP
Portfolio value
$20.0K
Annual income
$827.78
Full JNJ calculator →

Portfolio growth — RENEW vs JNJ

📍 RENEW pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodRENEWJNJ
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, RENEW + JNJ cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
RENEW pays
JNJ pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

RENEW
Annual income on $10K today (after 15% tax)
$124,816.45/yr
After 10yr DRIP, annual income (after tax)
$433,507,007,442,556.44/yr
JNJ
Annual income on $10K today (after 15% tax)
$285.83/yr
After 10yr DRIP, annual income (after tax)
$703.61/yr
At 15% tax rate, RENEW beats the other by $433,507,007,441,852.80/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of RENEW + JNJ for your $10,000?

RENEW: 50%JNJ: 50%
100% JNJ50/50100% RENEW
Portfolio after 10yr
$289165241.13M
Annual income
$255,004,122,025,447.06/yr
Blended yield
88.19%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on JNJ right now

RENEW
No analyst data
Altman Z
-0.4
Piotroski
5/9
JNJ
Analyst Ratings
20
Buy
17
Hold
3
Sell
Consensus: Buy
Price Target
$228.73
+55.1% upside vs current
Range: $190.00 — $265.00
Altman Z
5.2
Piotroski
4/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

RENEW buys
0
JNJ buys
0
No recent congressional trades found for RENEW or JNJ in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricRENEWJNJ
Forward yield1468.43%3.36%
Annual dividend / share$2.00$4.96
Payout ratio50%55%
1-year div growth0%4.2%
5-year div CAGR0%5.8%
Portfolio after 10y$578330482.24M$20.0K
Annual income after 10y$510,008,244,050,066.40$827.78
Total dividends collected$573345914.57M$5.6K
Payment frequencyquarterlyquarterly
SectorStockHealthcare

Year-by-year: RENEW vs JNJ ($10,000, DRIP)

YearRENEW PortfolioRENEW Income/yrJNJ PortfolioJNJ Income/yrGap
1← crossover$157,543$146,842.88$10,676$355.77+$146.9KRENEW
2$2,330,632$2,162,060.72$11,407$389.39+$2.32MRENEW
3$32,386,050$29,892,274.54$12,198$426.53+$32.37MRENEW
4$422,856,659$388,203,584.98$13,056$467.62+$422.84MRENEW
5$5,189,539,157$4,737,082,531.83$13,987$513.12+$5189.53MRENEW
6$59,885,695,249$54,332,888,350.74$14,998$563.56+$59885.68MRENEW
7$650,044,908,992$585,967,215,076.20$16,098$619.52+$650044.89MRENEW
8$6,639,972,418,087$5,944,424,365,465.88$17,295$681.69+$6639972.40MRENEW
9$63,852,559,053,985$56,747,788,566,631.71$18,599$750.82+$63852559.04MRENEW
10$578,330,482,237,831$510,008,244,050,066.40$20,022$827.78+$578330482.22MRENEW

RENEW vs JNJ: Complete Analysis 2026

RENEWStock

Cartesian Growth Corporation II focuses on effecting a merger, share exchange, asset acquisition, share purchase, reorganization, or other similar business combination with one or more businesses or entities. The company was incorporated in 2021 and is based in New York, New York.

Full RENEW Calculator →

JNJHealthcare

Johnson & Johnson is a Dividend King with 62+ years of consecutive dividend increases. A healthcare conglomerate spanning pharmaceuticals, MedTech, and consumer health. JNJ spun off its consumer segment as Kenvue in 2023, focusing on higher-margin pharma and medical devices.

Full JNJ Calculator →
📬

Get this RENEW vs JNJ comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

RENEW vs SCHDRENEW vs JEPIRENEW vs ORENEW vs KORENEW vs MAINRENEW vs ABBVRENEW vs MRKRENEW vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.